BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23033006)

  • 1. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.
    De Vuyst H; Mugo NR; Chung MH; McKenzie KP; Nyongesa-Malava E; Tenet V; Njoroge JW; Sakr SR; Meijer CM; Snijders PJ; Rana FS; Franceschi S
    Br J Cancer; 2012 Oct; 107(9):1624-30. PubMed ID: 23033006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.
    De Vuyst H; Mugo NR; Franceschi S; McKenzie K; Tenet V; Njoroge J; Rana FS; Sakr SR; Snijders PJ; Chung MH
    PLoS One; 2014; 9(10):e111037. PubMed ID: 25343563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
    Delory T; Ngo-Giang-Huong N; Rangdaeng S; Chotivanich N; Limtrakul A; Putiyanun C; Suriyachai P; Matanasarawut W; Jarupanich T; Liampongsabuddhi P; Heard I; Jourdain G; Lallemant M; Le Coeur S;
    J Infect; 2017 May; 74(5):501-511. PubMed ID: 28254419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
    Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
    Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
    van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
    Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
    Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
    JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 12. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis.
    Menon S; Luchters S; Rossi R; Callens S; Kishor M; Bogers J; Vanden Broeck D
    Virol J; 2018 Mar; 15(1):54. PubMed ID: 29587796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.
    Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH
    Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
    Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
    Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya.
    De Vuyst H; Chung MH; Baussano I; Mugo NR; Tenet V; van Kemenade FJ; Rana FS; Sakr SR; Meijer CJ; Snijders PJ; Franceschi S
    Int J Cancer; 2013 Sep; 133(6):1441-6. PubMed ID: 23444059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
    Kang YJ; Lewis H; Smith MA; Simonella L; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2015 Aug; 15():365. PubMed ID: 26297490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers.
    Cameron JE; Rositch AF; Vielot NA; Mugo NR; Kwatampora JKL; Waweru W; Gilliland AE; Hagensee ME; Smith JS
    Sex Transm Dis; 2018 Oct; 45(10):666-672. PubMed ID: 29664764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.